Literature DB >> 3720867

G6PD molecules devoid of catalytic activity are present in the nucleus of the rat lens.

A Dovrat, J Scharf, L Eisenbach, D Gershon.   

Abstract

The specific activity of glucoso-6-phosphate dehydrogenase (G6PD) in the rat lens declines as a function of animal age. G6PD activity could be found only in the cortex of the lens. Previous work showed that antibodies against the 'native' form of G6PD could not recognize any cross-reacting material (CRM) in the lens. It was speculated that this could be due either to disappearance of G6PD from the nucleus by degradation or by alterations of the molecules which resulted in the loss of their antigenic determinants. In order to investigate this question, an antibody was prepared against denatured G6PD. This antibody did not interact with 'native' (active) forms of the enzyme; it was shown, however, to recognize antigenically cross-reactive but catalytically inactive intact G6PD molecules in the nucleus of the lens. This finding suggests that altered enzyme molecules are at least partially denatured and accumulate in the lens without being further cleaved proteolytically.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3720867     DOI: 10.1016/0014-4835(86)90008-4

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  4 in total

1.  Counterpoint: The lens fluid circulation model--a critical appraisal.

Authors:  David C Beebe; Roger J W Truscott
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05       Impact factor: 4.799

2.  Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase.

Authors:  H Yan; J J Harding
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

3.  Localization of denatured enzyme molecules in rat lenses.

Authors:  J Scharf; A Dovrat; M Nahir
Journal:  Br J Exp Pathol       Date:  1988-06

Review 4.  Small molecules, both dietary and endogenous, influence the onset of lens cataracts.

Authors:  Stephen Barnes; Roy A Quinlan
Journal:  Exp Eye Res       Date:  2016-03-31       Impact factor: 3.467

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.